Salubris

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Precision Scientific is a provider of contract research organization (CRO) services aimed at enhancing cancer care for pharmaceutical and biotechnology companies. The company employs advanced AI technology, specifically its proprietary ALBERT system, which utilizes machine learning to analyze multi-omics data through data mining and predictive algorithms. This innovative approach supports oncology research by facilitating drug target discovery, biomarker identification, selection of indications, evaluation of drug resistance mechanisms, and strategies for combination therapies. Additionally, Precision Scientific offers integrated services that encompass clinical development, biomarker and companion diagnostic development, biometrics, regulatory strategy, and commercialization, catering to both pharmaceutical companies and academic or healthcare institutions.

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Mercator MedSystems, Inc. is a medical technology company based in Emeryville, California, specializing in catheter-guided microfluid injection systems for the targeted delivery of therapeutic agents across blood vessels. The company offers innovative products, including the Cricket and Bullfrog micro-infusion catheters, which facilitate the direct injection of therapies into deep tissues, thereby enhancing treatment efficacy while minimizing systemic exposure. Mercator's technology addresses various medical conditions, including blood vessel restenosis, peripheral artery disease, and neointimal hyperplasia associated with dialysis access failure. Their micro-infusion devices are designed to deliver drugs, genes, and cells without compromising viability or potency. The company's applications extend to treatments for plaque stabilization, anti-tumor therapies, and regenerative medicine. Founded in 1999, Mercator MedSystems aims to improve patient outcomes through precise and effective therapeutic delivery, ultimately advancing the field of vascular disease management and oncology.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, that specializes in precision oncology focused on virus-associated malignancies. The company utilizes a viral activation therapy platform to develop treatments for cancers linked to the Epstein-Barr Virus (EBV) and other virus-related diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir as a potential oral therapy for EBV-positive lymphoma, including post-transplant lymphoproliferative disorder, plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma. Viracta is also exploring the application of this approach to other EBV-associated conditions, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and rebranded from HemaQuest Pharmaceuticals in 2015, Viracta Therapeutics is actively conducting multiple clinical trials to advance its therapeutic candidates.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.

Jinjiang Electronic Technology is a med-tech company focused on the research and development as well as the manufacture of advanced medical equipment designed to enhance patient care in the field of cardiac electrophysiology. The company offers a range of innovative products, including a 3D cardiac mapping system, electrophysiology recording system, cardiac RF ablation generator, and irrigation pump. These devices provide comprehensive solutions aimed at diagnosing and treating arrhythmias, ultimately improving the quality of life for patients with heart conditions.

Go Therapeutics is a biotechnology company focused on developing innovative antibodies aimed at targeting tumor-specific glycoprotein antigens. The company utilizes advanced technologies to create antibodies that are highly specific to cancer cells by combining up-regulated protein expressions found in tumors with their unique glycosylation patterns. This approach significantly enhances the tumor-targeting capabilities of the antibodies, making them suitable for various cancer immunotherapies, including bi-specific antibody T-cell engagement, CAR-T, and antibody-drug conjugates (ADC). By concentrating on antigens that are absent in healthy cells, Go Therapeutics aims to provide effective cancer treatments while minimizing harm to normal tissue.

Zhongke Health Industry Group is a manufacturer of health care products. It provides goods for managing blood sugar, nourishing and guarding the liver, combating fatigue, and maintaining cardiovascular and cerebrovascular health. Their products include spore powder capsules, bovine colostrum capsules, and Ganoderma lucidum spore oil.